- Home
- PMVP vs BYSI Comparison
PMVP vs BYSI Comparison
Compare PMVP & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.14
HOLD
Current Price
$1.59
Company Overview
Basic Information| Metric | PMVP | BYSI |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.0M | 79.0M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | PMVP | BYSI |
|---|---|---|
| Price | $1.14 | $1.59 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 223.3K | 128.7K |
| Earning Date | 03-02-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.81 | $0.98 |
| 52 Week High | $1.84 | $3.44 |
Technical Indicators
Market Signals| Indicator | PMVP | BYSI |
|---|---|---|
| Relative Strength Index (RSI) | 36.47 | 43.96 |
| Support Level | $1.16 | $1.53 |
| Resistance Level | $1.26 | $1.66 |
| Average True Range (ATR) | 0.04 | 0.12 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 9.37 | 50.93 |
Price Performance
Historical Comparison PMVP
BYSI
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.